ATLANTA and ROUND ROCK, Texas, April 23, 2026 /PRNewswire/ -- Mikart, LLC ("Mikart"), a leader in formulation development, analytical testing, and finished dose manufacturing, and Benuvia Operations, ...
“We see a huge need to build U.S.-based manufacturing capabilities in this current environment, and bringing back drug manufacturing, high quality science and biopharma jobs to us, I think, is ...
Scheduled for August 2025 completion, the initial $2-billion phase included construction of a 1-million-sq-ft complex with two drug substance manufacturing buildings, each containing four 20,000-liter ...
Drug Substance manufacturing is a critical component of pharmaceutical production, requiring precise processes, rigorous quality control, and innovative solutions to overcome various challenges. From ...
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
Siegfried has recently inaugurated its new large-scale production facility for API manufacturing in Minden, Germany. With this, the company strengthens its position as one of the leading global CDMOs ...